Akumin (TSX:AKU) Tax Provision : C$2.0 Mil (TTM As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Akumin Tax Provision?

Akumin's tax provision for the three months ended in Sep. 2023 was C$0.1 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2023 was C$2.0 Mil.

Akumin Tax Provision Historical Data

The historical data trend for Akumin's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akumin Tax Provision Chart

Akumin Annual Data

Trend

Sep15

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Tax Provision

Get a 7-Day Free Trial

2.05

3.69

-0.72

38.90

-11.43

Akumin Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Tax Provision	Get a 7-Day Free Trial															-16.06	0.96	-1.20	2.10	0.11

Akumin Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.0 Mil.

Akumin (TSX:AKU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (TSX:AKU) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

AKUMQ:USA

Address

8300 West Sunrise Boulevard, Plantation, FL, USA, 33322

Website

https://www.akumin.com

Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.

Executives

Marcus Quesenberry	Senior Officer
Amy Michelle Adams	Senior Officer

Akumin (TSX:AKU) Headlines

No Headlines